Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
IGF
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
ganitumab
(AMG 479) / Takeda, ImmunityBio
linsitinib
(ASP7487) / Sling Therap
dalotuzumab
(MK 0646) / Merck (MSD), Pierre Fabre
figitumumab
(CP-751,871) / Novartis
VRDN-001
/ Viridian Therap
Oclaiz
(octreotide subcutaneous depot) / Camurus
IBI311
/ Innovent Biologics
Mycapssa
(octreotide) / Chiesi
conteltinib
(SY-707) / Centaurus Biopharma, Shouyao Holdings
teprotumumab subcutaneous
/ Xeris Biopharma
